Evidence map›Paper›PMID 35767994›Full record

ArticleNeuron2022

Overlapping transcriptional programs promote survival and axonal regeneration of injured retinal ganglion cells.

Anne Jacobi, Nicholas M Tran, Wenjun Yan, Inbal Benhar, Feng Tian, Rebecca Schaffer, Zhigang He, Joshua R Sanes

Open access · greenAbstract read
In one paragraph

Article in Neuron, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 1 pooled it
14.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 1 synthesis or guideline pooled it, 153 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Anne JacobiF.M. Kirby Neurobiology Center, Boston Children's Hospital, and Department of Neurology, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA; Department of Molecular and Cellular Biology, Center for Brain Science, Harvard University, 52 Oxford Street, Cambridge, MA 02138, USA.
Nicholas M TranDepartment of Molecular and Cellular Biology, Center for Brain Science, Harvard University, 52 Oxford Street, Cambridge, MA 02138, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA.
Wenjun YanDepartment of Molecular and Cellular Biology, Center for Brain Science, Harvard University, 52 Oxford Street, Cambridge, MA 02138, USA.
Inbal BenharBroad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
Feng TianF.M. Kirby Neurobiology Center, Boston Children's Hospital, and Department of Neurology, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA.
Rebecca SchafferDepartment of Molecular and Cellular Biology, Center for Brain Science, Harvard University, 52 Oxford Street, Cambridge, MA 02138, USA.
Zhigang HeF.M. Kirby Neurobiology Center, Boston Children's Hospital, and Department of Neurology, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA. Electronic address: zhigang.he@childrens.harvard.edu.
Joshua R SanesDepartment of Molecular and Cellular Biology, Center for Brain Science, Harvard University, 52 Oxford Street, Cambridge, MA 02138, USA. Electronic address: sanesj@mcb.harvard.edu.
Harvard University · USBoston Children's Hospital · USBroad Institute · US

Funding

SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI WOOLF, CLIFFORD J · 1985 to 2015
$26.2M
Viral ModuleP30EY012196 · NEI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ZHIGANG HE · 1998 to 2026
$21.3M
Genetic Analysis and Manipulation Core (GAEC)P50HD105351 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Hisashi Umemori · 2021 to 2026
$9.4M
SOCS3 and optic nerve regenerationR01EY021526 · NEI · BOSTON CHILDREN'S HOSPITAL · PI HE, ZHIGANG · 2011 to 2020
$4.1M
CRSIPR screening for novel regulators of retinal ganglion cell survival and axonal regenerationR01EY030204 · NEI · BOSTON CHILDREN'S HOSPITAL · PI HE, ZHIGANG, SANES, JOSHUA R · 2019 to 2023
$2.7M
Reprogramming Strategies of Promoting Optic Nerve Regeneration and Vision RestorationR01EY026939 · NEI · BOSTON CHILDREN'S HOSPITAL · PI HE, ZHIGANG · 2016 to 2020
$2.2M
New Approach to promote optic nerve regeneration and vision restorationR01EY021342 · NEI · BOSTON CHILDREN'S HOSPITAL · PI HE, ZHIGANG · 2011 to 2014
$1.7M
Epigenomic mechanisms regulating RGC survival and axon regenerationR00EY032181 · NEI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Feng Tian · 2024 to 2026
$750k
Determinants of type-dependent retinal ganglion cell resilience: potential targets for neuroprotection and axon regenerationR00EY029360 · NEI · BAYLOR COLLEGE OF MEDICINE · PI TRAN, NICHOLAS MINH ABELL · 2021 to 2023
$740k
Cell type-specific vulnerability of neurons to axonal injury: comprehensive mapping of types and gene expression analyzed by high throughput single cell RNAseqR21NS104248 · NINDS · HARVARD UNIVERSITY · PI SANES, JOSHUA R · 2017 to 2018
$465k
Epigenomic mechanisms regulating RGC survival and axon regenerationK99EY032181 · NEI · BOSTON CHILDREN'S HOSPITAL · PI TIAN, FENG · 2021 to 2023
$282k
Determinants of type-dependent retinal ganglion cell resilience: potential targets for neuroprotection and axon regenerationK99EY029360 · NEI · HARVARD UNIVERSITY · PI TRAN, NICHOLAS MINH ABELL · 2018 to 2020
$268k
NEI NIH HHS K99 EY029360NEI NIH HHS K99 EY032181NEI NIH HHS P30 EY012196NEI NIH HHS R00 EY029360NEI NIH HHS R00 EY032181NEI NIH HHS R01 EY021342NEI NIH HHS R01 EY021526NEI NIH HHS R01 EY026939NEI NIH HHS R01 EY030204NICHD NIH HHS P30 HD018655NICHD NIH HHS P50 HD105351NINDS NIH HHS R21 NS104248
6 · The paper itself

Abstract

Injured neurons in the adult mammalian central nervous system often die and seldom regenerate axons. To uncover transcriptional pathways that could ameliorate these disappointing responses, we analyzed three interventions that increase survival and regeneration of mouse retinal ganglion cells (RGCs) following optic nerve crush (ONC) injury, albeit not to a clinically useful extent. We assessed gene expression in each of 46 RGC types by single-cell transcriptomics following ONC and treatment. We also compared RGCs that regenerated with those that survived but did not regenerate. Each intervention enhanced survival of most RGC types, but type-independent axon regeneration required manipulation of multiple pathways. Distinct computational methods converged on separate sets of genes selectively expressed by RGCs likely to be dying, surviving, or regenerating. Overexpression of genes associated with the regeneration program enhanced both survival and axon regeneration in vivo, indicating that mechanistic analysis can be used to identify novel therapeutic strategies.

Indexed as

Optic Nerve InjuriesRetinal Ganglion CellsAnimalsAxonsCell SurvivalMammalsMiceNerve Regenerationaxonal regenerationCNTFPtensingle-cell RNA sequencingSocs3Wt1

Identifiers

PMID35767994
PMCPMC9391321
OpenAlexW4283693076

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.